Eris Lifesciences Limited has informed the Exchange about Schedule of meet
ERIS · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Eris Lifesciences Limited has informed the stock exchanges about its schedule of meetings, typically with analysts or institutional investors. The specific dates, participants, and venues are not detailed in the available headline. Such filings are usually made under SEBI's Regulation 30 disclosure requirements ahead of investor interactions.
Schedule-of-meet filings are routine compliance disclosures and generally do not have a direct impact on stock price. However, what is discussed in these meetings (growth outlook, guidance, or new launches) can influence investor sentiment if shared broadly.